Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer

Clinical Biochemistry

Volumn 63, Issue , 2019, Pages 32-38

  Mihajlovic, Marija ^a   Gojkovic, Tamara ^a   Vladimirov, Sandra ^a   Miljkovic, Milica ^a   Stefanovic, Aleksandra ^a   Vekic, Jelena ^a   Zeljkovic, Dejan ^b   Trifunovic, Bratislav ^b,c   Kotur Stevuljevic, Jelena ^a   Spasojevic Kalimanovska, Vesna ^a   Zeljkovic, Aleksandra ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c Serbia   (Serbia)

Author keywords

Cholesteryl ester transfer protein; Colorectal cancer; Lecithin:cholesterol acyltransferase; Paraoxonase 1; Prooxidant antioxidant balance

Indexed keywords

ALBUMIN; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID TRANSFER PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN; CETP PROTEIN, HUMAN; LCAT PROTEIN, HUMAN; PON1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; FEMALE; GLUCOSE LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; AGED; BLOOD; CLINICAL TRIAL; COLORECTAL TUMOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL ESTER TRANSFER PROTEINS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 85057453833     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2018.11.010     Document Type: Article

References (40)

1. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136 (2015), E359–E386.
2. Bai, S., Feng, Q., Pan, X.Y., Zou, H., Chen, H.B., Wang, P., Zhou, X.L., Hong, Y.L., Song, S.L., Yang, J.L., Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. Int. J. Mol. Med. 39 (2017), 861–868.
3. Wachsmannova, L., Mego, M., Stevurkova, V., Zajac, V., Ciernikova, S., Novel strategies for comprehensive mutation screening of the APC gene. Neoplasma 64 (2017), 338–343.
4. Liu, K., Moss, D., Persky, V., Stamler, J., Garside, D., Soltero, I., Dietary cholesterol, fat, and fibre, and colon-cancer mortality: an analysis of international data. Lancet 314 (1979), 782–785.
5. Marley, A.R., Nan, H., Epidemiology of colorectal cancer. Int. J. Mol. Epidemiol. Genet., 7, 2016, 105.
6. Passarelli, M.N., Newcomb, P.A., Blood lipid concentrations and colorectal adenomas: a systematic review and meta-analysis of colonoscopy studies in Asia, 2000–2014. Am. J. Epidemiol. 183 (2016 Mar 24), 691–700.
7. Yao, X., Tian, Z., Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies. Cancer Causes Control 26 (2015), 257–268.
8. Park, Y.M., Kim, H.S., Park, J.J., Baik, S.J., Youn, Y.H., Kim, J.H., Park, H., A simple scoring model for advanced colorectal neoplasm in asymptomatic subjects aged 40–49 years. BMC Gastroenterol., 17, 2017, 7.
9. van Duijnhoven, F.J., Bueno-De-Mesquita, H.B., Calligaro, M., Jenab, M., Pischon, T., Jansen, E.H., Frohlich, J., Ayyobi, A., Overvad, K., Toft-Petersen, A.P., Tjønneland, A., Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 60 (2011), 1094–1102 Gut-2010.
10. Klatt, P., Lamas, S., Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur. J. Biochem. 267 (2000), 4928–4944.
11. Evans, M.D., Dizdaroglu, M., Cooke, M.S., Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 567 (2004), 1–61.
12. Strzelczyk, J.K., Wielkoszyński, T., Krakowczyk, Ł., Adamek, B., Zalewska-Ziob, M., Gawron, K., Kasperczyk, J., Wiczkowski, A., The activity of antioxidant enzymes in colorectal adenocarcinoma and corresponding normal mucosa. Acta Biochim. Pol. 59 (2012), 549–556.
13. Skrzydlewska, E., Sulkowski, S., Koda, M., Zalewski, B., Kanczuga-Koda, L., Sulkowska, M., Lipid peroxidation and antioxidant status in colorectal cancer. World J. Gastroenterol. 11 (2005), 403–406.
14. Alamdari, D.H., Paletas, K., Pegiou, T., Sarigianni, M., Befani, C., Koliakos, G., A novel assay for the evaluation of the prooxidant–antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin. Biochem. 40 (2007), 248–254.
15. Kontush, A., Chapman, M.J., Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr. Opin. Lipidol. 21 (2010), 312–318.
16. Asztalos, B.F., Swarbrick, M.M., Schaefer, E.J., Dallal, G.E., Horvath, K.V., Ai, M., Stanhope, K.L., Austrheim-Smith, I., Wolfe, B.M., Ali, M., Havel, P.J., Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J. Lipid Res. 51 (2010), 2405–2412.
17. Richter, R.J., Jarvik, G.P., Furlong, C.E., Paraoxonase 1 status as a risk factor for disease or exposure. Adv. Exp. Med. Biol. 660 (2010), 29–35.
18. Ceron, J.J., Tecles, F., Tvarijonaviciute, A., Serum paraoxonase 1 (PON1) measurement: an update. BMC Vet. Res., 10, 2014, 74.
19. Krzystek-Korpacka, M., Boehm, D., Matusiewicz, M., Diakowska, D., Grabowski, K., Gamian, A., Paraoxonase 1 (PON-1) status in gastroesophageal malignancies and associated paraneoplastic syndromes connection with inflammation. Clin. Biochem. 41 (2008), 804–811.
20. Šimundić A.M., Measures of diagnostic accuracy: basic definitions. EJIFCC. 19:4 (2009), 203–211.
21. Notarnicola, M., Altomare, D.F., Correale, M., Ruggieri, E., D'Attoma, B., Mastrosimini, A., Guerra, V., Caruso, M.G., Serum lipid profile in colorectal cancer patients with and without synchronous distant metastases. Oncology 68 (2005), 371–374.
22. Ziętarska, M., Krawczyk-Lipiec, J., Kraj, L., Zaucha, R., Małgorzewicz, S., Nutritional status assessment in colorectal cancer patients qualified to systemic treatment. Contemp. Oncol. (Pozn). 21 (2017), 157–161.
23. Kaneko, R., Tsuji, N., Asanuma, K., Tanabe, H., Kobayashi, D., Watanabe, N., Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor-induced apoptosis in cancer. J. Biol. Chem. 282 (2007), 19273–19281.
24. Abaza, H., Ghanem, A., Jmal, A., Harzallah, L., Rahal, K., Guemira, F., Changes in serum lipids in patients with colorectal cancer. Tunis Med. 89 (2011), 147–150.
25. Beloribi-Djefaflia, S., Vasseur, S., Guillaumond, F., Lipid metabolic reprogramming in cancer cells. Oncogene, 5, 2016, e189.
26. Liao, F., He, W., Jiang, C., Yin, C., Guo, G., Chen, X., Qiu, H., Rong, Y., Zhang, B., Xu, D., Xia, L., A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C. Onco. Targets Ther. 8 (2015), 3135–3142.
27. Li, C.F., Li, J., Bai, P., Lv, Y.M., Characteristic analysis of plasma lipid metabolism level in patients with colorectal adenoma. Beijing Da Xue Xue Bao 43 (2011), 432–435.
28. Wang, Y., Wang, Z.Q., Wang, F.H., Lei, X.F., Yan, S.M., Wang, D.S., Zhang, F., Xu, R.H., Wang, L.Y., Li, Y.H., Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases. Oncotarget 7 (2016), 57290–57300.
29. Zamanian-Daryoush, M., Lindner, D., Tallant, T.C., Wang, Z., Buffa, J., Klipfell, E., Parker, Y., Hatala, D., Parsons-Wingerter, P., Rayman, P., Yusufishaq, M.S., Fisher, E.A., Smith, J.D., Finke, J., Didonato, J.A., Hazen, S.L., The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects. J. Biol. Chem. 288 (2013), 21237–21252.
30. Ossoli, A., Simonelli, S., Vitali, C., Franceschini, G., Calabresi, L., Role of LCAT in atherosclerosis. J. Atheroscler. Thromb. 23 (2016), 119–127.
31. Kunken, S., Van Eck, M., Lecithin: cholesterol acyltransferase: old friend or foe in atherosclerosis?. J. Lipid Res. 53 (2012), 1783–1799.
32. Zhang, X., Zhao, X.W., Liu, D.B., Han, C.Z., Du, L.L., Jing, J.X., Wang, Y., Lipid levels in serum and cancerous tissues of colorectal cancer patients. World J. Gastroenterol. 20 (2014), 8646–8652.
33. Murakami, T., Michelagnoli, S., Longhi, R., Gianfranceschi, G., Pazzucconi, F., Calabresi, L., Sirtori, C.R., Franceschini, G., Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler. Thromb. Vasc. Biol. 15 (1995), 1819–1828.
34. Guo, S.X., Yao, M.H., Ding, Y.S., Zhang, J.Y., Yan, Y.Z., Liu, J.M., Zhang, M., Rui, D.S., Niu, Q., He, J., Guo, H., Ma, R.L., Associations of cholesteryl ester transfer protein TaqIB polymorphism with the composite ischemic cardiovascular disease risk and HDL-C concentrations: a meta-analysis. Int. J. Environ. Res. Public Health, 13(9), 2016, 10.3390/ijerph13090882 pii:E882.
35. Bu, X.M., Niu, D.M., Wu, J., Yuan, Y.L., Song, J.X., Wang, J.J., Elevated levels of preβ1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease. Lipids Health Dis., 16, 2017, 4.
36. Esau, L., Sagar, S., Bangarusamy, D., Kaur, M., Identification of CETP as a molecular target for estrogen positive breast cancer cell death by cholesterol depleting agents. Genes Cancer. 7 (2016), 309–322.
37. Ribas, V., García-Ruiz, C., Fernández-Checa, J.C., Mitochondria, cholesterol and cancer cell metabolism. Clin. Transl. Med., 5, 2016, 22.
38. Kontush, A., Chapman, M.J., Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58 (2006), 342–374.
39. Gopčević K.R., Rovčanin, B.R., Tatić S.B., Krivokapić Z.V., Gajić M.M., Dragutinović V.V., Activity of superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase in different stages of colorectal carcinoma. Dig. Dis. Sci. 58 (2013), 2646–2652.
40. Kraus, S., Arber, N., Inflammation and colorectal cancer. Curr. Opin. Pharmacol. 9 (2009), 405–410.